ABBV logo

ABBV

AbbVie Inc.

$222.59
+$0.12(+0.05%)
75
Overall
60
Value
90
Tech
--
Quality
Market Cap
$393.01B
Volume
5.91M
52W Range
$163.81 - $223.49
Target Price
$226.08
Order:

Income Statement

MetricTrendChart
2015
Dec
2016
Dec
2017
Dec
2018
Dec
2019
Dec
2020
Dec
2021
Dec
2022
Dec
2023
Dec
2024
Dec
REVENUE
Total Revenue
$22.9B$25.6B$28.2B$32.8B$33.3B$45.8B$56.2B$58.1B$54.3B$56.3B
Total Revenue
$22.9B$25.6B$28.2B$32.8B$33.3B$45.8B$56.2B$58.1B$54.3B$56.3B
COST OF GOODS SOLD
Cost of Revenue
$4.5B$5.8B$7.0B$7.7B$7.4B$15.4B$17.4B$17.4B$20.4B$16.9B
GROSS PROFIT
Gross Profit
$18.4B$19.8B$21.2B$25.0B$25.8B$30.4B$38.8B$40.6B$33.9B$39.4B
OPERATING EXPENSES
Operating Expenses
$10.8B$10.4B$11.6B$18.7B$12.8B$19.1B$20.8B$21.8B$21.1B$30.3B
Research & Development
$4.4B$4.6B$5.3B$10.8B$6.8B$7.8B$8.0B$7.2B$8.5B$15.6B
Research Expense
$4.3B$4.4B$5.0B$10.3B$6.4B$6.6B$6.9B$6.5B$7.7B$12.8B
Selling, General & Administrative
$6.4B$5.9B$6.3B$7.4B$6.9B$11.3B$12.3B$15.3B$12.9B$14.8B
Selling & Marketing Expenses
$704.0M$764.0M$846.0M$1.1B$1.1B$1.8B$2.1B$2.0B$2.2B$2.1B
General & Administrative Expenses
$6.4B$5.9B$6.3B$7.4B$6.9B$11.3B$12.3B$15.3B$12.9B$14.8B
Promotion & Advertising
$704.0M$764.0M$846.0M$1.1B$1.1B$1.8B$2.1B------
Salaries & Wages
$-89.0M$-104.0M$-73.0M$-73.0M$-80.0M$-131.0M$-126.0M------
Depreciation & Amortization
$417.0M$425.0M$425.0M$471.0M$464.0M$666.0M$803.0M$778.0M$752.0M$764.0M
Depreciation & Amortization
$417.0M$425.0M$425.0M$471.0M$464.0M$666.0M$803.0M------
Amortization
$19.7B$28.9B$27.6B$21.2B$18.6B$82.9B$76.0B$67.4B$55.6B$60.1B
Other Operating Expenses
$-187.0M$-118.0M$-1.8B$500.0M$-890.0M$-91.0M$432.0M$56.0M$-179.0M$-7.0M
OPERATING INCOME
Operating income
$7.5B$9.4B$9.5B$6.4B$13.0B$11.4B$17.9B$18.1B$12.8B$9.1B
EBITDA
$8.2B$10.1B$10.4B$8.3B$12.3B$12.3B$23.9B$24.2B$17.1B$14.9B
NON-OPERATING ITEMS
Interest Expense (Non-Operating)
$719.0M$1.0B$1.1B$1.3B$1.8B$2.5B$2.4B$2.2B$2.2B$2.8B
Intinc
$-686.0M$-965.0M$-1.0B$-1.1B$-1.5B$-2.3B$-2.4B$-2.0B$-1.7B$-2.2B
Net Non-Operating Interest Income/Expense
$-686.0M$-965.0M$-1.0B$-1.1B$-1.5B$-2.3B$-2.4B$-2.0B$-1.7B$-2.2B
Gain on Sale of Securities
$218.0M$-252.0M$90.0M--------------
Other Income/Expense
$13.0M$232.0M$466.0M$18.0M$3.0B$5.6B$2.5B$-3.3B$4.7B$3.2B
Other Special Charges
$-13.0M$-232.0M$-466.0M$-18.0M$-3.0B$-5.6B$-2.5B$-2.4B$-4.7B$-3.2B
SPECIAL ITEMS
Restructring And Mn A Income
$126.0M$52.0M$86.0M$59.0M$219.0M----------
Special Income Charges
$-126.0M$-52.0M$-440.0M$-59.0M$-219.0M------$2.9B$4.6B
Impairment of Capital Assets
----$354.0M--------------
PRE-TAX INCOME
EBIT
$7.4B$8.9B$8.9B$6.5B$10.2B$5.9B$15.4B$15.7B$8.5B$6.5B
Pre-Tax Income
$6.6B$7.9B$7.7B$5.2B$8.4B$3.4B$13.0B$13.5B$6.3B$3.7B
INCOME TAX
Tax Provision
$1.5B$1.9B$2.4B$-490.0M$544.0M$-1.2B$1.4B$1.6B$1.4B$-570.0M
NET INCOME
Net Income
$5.1B$6.0B$5.3B$5.7B$7.9B$4.6B$11.5B$11.8B$4.9B$4.3B
Net Income (Continuing Operations)
$5.1B$6.0B$5.3B$5.7B$7.9B$4.6B$11.5B$11.8B$4.9B$4.3B
Net Income (Discontinued Operations)
$5.1B$6.0B$5.3B$5.7B$7.9B$4.6B$11.5B$11.8B$4.9B$4.3B
Net Income (Common Stockholders)
$5.1B$6.0B$5.3B$5.7B$7.9B$4.6B$11.5B$11.8B$4.9B$4.3B
Normalized Income
$4.4B$5.4B$6.1B$4.8B$9.7B$2.2B--------
TOTALS
Total Expenses
$15.3B$16.3B$18.7B$26.4B$20.3B$34.4B$38.2B$39.2B$41.6B$47.2B
SHARE & EPS DATA
Average Shares Outstanding
$1.6B$1.6B$1.6B$1.5B$1.5B$1.7B$1.8B$1.8B$1.8B$1.8B
Average Shares Outstanding (Diluted)
$1.6B$1.6B$1.6B$1.5B$1.5B$1.7B$1.8B$1.8B$1.8B$1.8B
Shares Outstanding
$1.6B$1.6B$1.6B$1.5B$1.5B$1.8B$1.8B$1.8B$1.8B$1.8B
Basic EPS
$3.15$3.65$3.31$3.67$5.3$2.73$6.48$6.65$2.73$2.4
Basic EPS (Continuing Operations)
$3.15$3.65$3.31$3.67$5.3$2.73$6.48$6.65$2.73$2.4
Diluted EPS
$3.13$3.63$3.3$3.66$5.28$2.72$6.45$6.63$2.72$2.39
Diluted EPS (Continuing Operations)
$3.13$3.63$3.3$3.66$5.28$2.72$6.45$6.63$2.72$2.39
Dividend Per Share
$2.1$2.35$2.63--$4.39$4.84$5.31$5.71$5.99$6.29
OTHER METRICS
Development Expense
$150.0M$200.0M$327.0M$424.0M$385.0M$1.2B$1.1B$697.0M$778.0M$2.8B
Gain On Sale Of P P E
------------$68.0M------
Minority Interests
--------$-8.2B$-6.0M$-7.0M$-9.0M$-10.0M$-8.0M
Other Gand A
$6.4B$5.9B$6.3B$7.4B$6.9B$11.3B$12.3B$15.3B$12.9B$14.8B
Other Impairment Of Capital Assets
------------$50.0M------
Rent And Landing Fees
$146.0M$159.0M$169.0M$161.0M------------
Restruct
$126.0M$52.0M$86.0M$59.0M$219.0M----------

Financial data is updated quarterly and may not reflect the most recent earnings.

ABCD
1SymbolPriceChangeVol
2ABBV$222.59+0.1%5.91M
3
4
5
6

Get AbbVie Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.